Stay updated on FMX103 Topical Minocycline Foam in Rosacea Clinical Trial
Sign up to get notified when there's something new on the FMX103 Topical Minocycline Foam in Rosacea Clinical Trial page.

Latest updates to the FMX103 Topical Minocycline Foam in Rosacea Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedIntroduces a consolidated 'Locations' section listing all participating states (Arizona, California, Florida, Georgia, Indiana, Louisiana, Massachusetts, Michigan, Missouri, Nebraska, Nevada, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah). The previous state-specific sections (e.g., 'Arizona Locations') are removed and a 'Revision: v3.3.3' tag is now shown.SummaryDifference2%

- Check56 days agoChange DetectedThe site revision changed from v3.2.0 to v3.3.2 with no visible changes to study content, navigation, or data presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedPremier Research is added as a collaborator on the study page. The listing for Premier Research Group plc has been removed, and the government funding status notice has been deleted.SummaryDifference0.3%

- Check85 days agoChange DetectedResults for the study have been posted, including primary and secondary efficacy outcomes and safety data. The posting date is 2020-12-17.SummaryDifference0.4%

- Check106 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference3%

Stay in the know with updates to FMX103 Topical Minocycline Foam in Rosacea Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FMX103 Topical Minocycline Foam in Rosacea Clinical Trial page.